KM
Kandru Madhavarao
About Kandru Madhavarao
Data last updated:
Kandru Madhavarao is a Director at Credo Life Sciences Private Limited (since 2015) and Director at Credo Pharma Private Limited (since 2013). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Credo Life Sciences Private Limited at ₹100 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Credo Life Sciences Private Limited U24232TG2014PTC112849 | Director | 01 Apr 2015 | 2014 | ₹100 Cr (FY 2024) | Active |
 Credo Pharma Private Limited U24232TG2013PTC089087 | Director | 23 Jul 2013 | 2013 | ₹2.15 Cr (FY 2025) | Active |
Board colleagues of Kandru Madhavarao
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aluru Vamsi Krishna | 06572638 | Credo Life Sciences Private Limited , Credo Pharma Private Limited | Director |
| Siva Rama Prasad Aluru | 00361671 | Credo Life Sciences Private Limited , Credo Pharma Private Limited | Managing Director |
| Aluru Narmada | 07097387 | Credo Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kandru Madhavarao
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kandru Madhavarao
Kandru Madhavarao currently holds 2 directorships: Credo Life Sciences Private Limited (Director, since 01 Apr 2015, revenue ₹100 Cr (FY 2024)); Credo Pharma Private Limited (Director, since 23 Jul 2013, revenue ₹2.15 Cr (FY 2025)).
Kandru Madhavarao was first appointed on 23 Jul 2013 as Director at Credo Pharma Private Limited. The most recent appointment on record is 01 Apr 2015 at Credo Life Sciences Private Limited.
The 2 current companies of Kandru Madhavarao that report revenue have a combined latest revenue of ₹103 Cr: Credo Life Sciences Private Limited ₹100 Cr (FY 2024); Credo Pharma Private Limited ₹2.15 Cr (FY 2025).
The current boards of Kandru Madhavarao's companies include Aluru Vamsi Krishna (Credo Life Sciences Private Limited), Siva Rama Prasad Aluru (Credo Life Sciences Private Limited), Aluru Narmada (Credo Pharma Private Limited).